You are here

ENSION Inc

Company Information
Address
508 PITTSBURGH RD
BUTLER, PA 16002-7658
United States


http://www.ension.com

Information

UEI: Y4P6UDJLXLN3

# of Employees: 7


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Magnetic levitation motor for pediatric cardiac and cardiopulmonary therapies- Phase II

    Amount: $1,451,404.00

    Abstract This Phase II STTR application represents the main research and development effort for an innovative, low cost, magnetic levitation motor specifically designed for neonatal and pediatric extr ...

    STTRPhase II2020Department of Health and Human Services National Institutes of Health
  2. System and comprehensive approach for blood compatibility of medical devices and biomaterial

    Amount: $1,261,442.00

    AbstractTo dateblood compatibility testing of biomaterials and medical devices has not led to a consensus on what materials are non thrombogenic nor has it advanced understanding of what and how varia ...

    SBIRPhase II2019Department of Health and Human Services National Institutes of Health
  3. Development of bioactive surface for pediatric hemodialysis catheters to prevent thrombogenic inflammatory and biofilm complications

    Amount: $299,832.00

    DESCRIPTION provided by applicant The most common hemodialysis catheter complications are thrombosis inflammation and biofilms Thrombotic deposition and inflammation have been shown to result i ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  4. Magnetic levitation motor for pediatric cardiac and cardiopulmonary therapies

    Amount: $356,976.00

    Abstract This Phase I STTR application proposes development of an innovative low cost magnetic levitation motor specifically designed for pediatric extracorporeal cardiac and cardiopulmonary therapi ...

    STTRPhase I2016Department of Health and Human Services National Institutes of Health
  5. System and comprehensive approach for blood compatibility of medical devices and biomaterials

    Amount: $257,843.00

    DESCRIPTION provided by applicant To date blood compatibility testing of biomaterials and medical devices has not led to a consensus on what materials are non thrombogenic nor has it advanced und ...

    SBIRPhase I2016Department of Health and Human Services National Institutes of Health
  6. Architecturally Enhanced and Reinforced Regenerative Collagen Matrix for Wound Healing Applications

    Amount: $224,971.00

    DESCRIPTION provided by applicant The objective of the proposed Phase I SBIR is to develop and evaluate the ability of a novel regenerative collagen matrix RCM to prevent scarring and contracture ...

    SBIRPhase I2015Department of Health and Human Services National Institutes of Health
  7. Infection resistant surface for ventricular assist device (VAD) transcutaneous dr

    Amount: $880,733.00

    DESCRIPTION (provided by applicant): Infection is a common and frequently very serious complication associated with medical implants. Man-made materials, including those used to fabricate ventricular ...

    SBIRPhase II2014Department of Health and Human Services National Institutes of Health
  8. Infection resistant surface for ventricular assist device (VAD) transcutaneous dr

    Amount: $1,272,262.00

    DESCRIPTION (provided by applicant): Infection is a common and frequently very serious complication associated with medical implants. Man-made materials, including those used to fabricate ventricular ...

    SBIRPhase I2013Department of Health and Human Services National Institutes of Health
  9. Infection resistent coatings for mechanical circulatory support systems (MCSS)

    Amount: $157,723.00

    DESCRIPTION (provided by applicant): The high risk of infection posed by the use of paracorporeal and implanted mechanical circulatory support systems (MCSS) continues to create significant clinical c ...

    SBIRPhase I2009Department of Health and Human Services National Institutes of Health
  10. Biocompatible Coating for Pediatric Blood Oxygenators- Phase II

    Amount: $1,577,490.00

    DESCRIPTION (provided by applicant): Many oxygenators clinically available for pediatric (and adult) extracorporeal membrane oxygenation (ECMO) utilize heparin coatings such as Carmeda BioActive Surfa ...

    SBIRPhase II2008Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government